Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Live Cell Imaging
... at a CAGR of 7.5% over the analysis period 2024-2030. Live Cell Imaging Instruments, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.9 Billion by the ... Read More
-
Cell Harvesting
... CAGR of 7.6% over the analysis period 2024-2030. Peripheral Blood, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$271.0 Million by the end of the analysis ... Read More
-
Cord Blood Banking Services
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Private, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$79.3 Billion by the end ... Read More
-
Stem Cell Services
... at a CAGR of 9.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 9.0% CAGR The Stem Cell Services market in the U.S. ... Read More
-
CAR-T Funding Report – Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025
... a funding boom. Today, CAR-T start-ups are being richly funded by investors and large pharma who are eager to get into this trending area of regenerative medicine. Worldwide, more than 170 companies are now developing ... Read More
-
Apoptosis Inhibitor - Pipeline Insight, 2025
... for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages Clinical ... Read More
-
Red Biotechnology Market, By Product Type (Biopharmaceuticals, Biosimilars, Gene Therapy, Tissue Engineering, Cell Therapy), By Application (Drug Discovery & Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial Biotechnology, Agricultural Biotechnology, Others), By End User (Pharmaceutical & Biopharmaceutical Companies, Research Institutes, Biotechnology Industry, Hospitals & Diagnostic Centers, Academic Institutions), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... the treatment and prevention of diseases. Market Dynamics: Red biotechnology market is driven by several factors. These include the increasing global healthcare needs due to aging populations, rising chronic diseases, and pandemics. Advances in genomics, ... Read More
-
High End Cellomics Market, By Product Type (Instruments, Reagents and Consumables, and Software & Services), By Application (Drug discovery, Cancer Research, Neuroscience, Stem Cell Research and Regenerative Medicine, Personalized Medicine, and Others), By Technology (Microscopy, Flow Cytometry, Single-cell Genomics, Mass Spectrometry, Next Generation Sequencing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... for the study of cells at a molecular level. These technologies enable scientists and researchers to analyze cell structure, function, and dynamics, leading to important advancements in various fields such as drug discovery, disease diagnosis, ... Read More
-
Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy (Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Others), By Indication (Spinal Cord Injury, Stroke, Traumatic Brain Injury, Parkinson\\\'s Disease, Alzheimer\\\'s Disease, Multiple Sclerosis, Peripheral Nerve Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a ... Read More
-
Fanconi Anemia Drug Market, By Treatment Type (Hematopoietic Growth Factors, Gene Therapy, Stem Cell Transplantation, and Other Therapies), By Age Group (Pediatric Patients and Adult Patients), By Disease Stage (Early-stage Disease and Advanced-stage Disease), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... disorder that is marked by bone marrow failure, congenital defects, and an increased risk of developing cancer. Numerous organ systems are impacted by fanconi anemia. Fanconi anemia results from a defective gene that harms cells, ... Read More
-
Orthopedic Regenerative Medicine Market, By Type (Stem Cell, Biomaterial and Tissue Engineering), By Application (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Burisitis, Osteoporosis and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
... delay the need for surgery. With regenerative orthopedic therapy, healing elements that the body naturally produces are extracted, prepared, and then injected into the areas of the body that need healing, all without drugs or ... Read More
-
Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
... growth rate (CAGR) projection. It provides an overview of the industry structure and its competitive landscape. Leading market players’ profiles, product offerings, financial information and recent market activities are provided. This report also assesses companies’ ... Read More
-
Digital Twins in Healthcare Market by Therapeutic Area
... at a CAGR of 30% during the forecast period, till 2035. The market opportunity for cell and gene therapy supply chain software has been distributed across the following segments: Therapeutic Area Cardiovascular Disorders Metabolic Disorders ... Read More
-
2025 Human Reproductive and Stem Cell Bank Services Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling human reproductive and ... Read More
-
Viral Vector Market Size, Share, and Outlook, 2025 Report- By Type (Adeno-associated virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), By Application (Cell & Gene Therapy, Vaccine, Biopharmaceutical & Pharmaceutical Discovery), By End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, CROs & CMOs), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Viral Vector segments across 22 countries from 2021 to 2032. ... Read More
-
Plasmid DNA Manufacturing Market Size, Share, and Outlook, 2025 Report- By Grade (R&D Grade, GMP Grade), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics), By Application (DNA Vaccines, Cell & Gene Therapy, Immunotherapy, Others), By Disease (Infectious Disease, Cancer, Genetic Disorder, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Plasmid DNA Manufacturing segments across 22 countries ... Read More
-
Red Biotechnology Market Size, Share, and Outlook, 2025 Report- By Product (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products, Gene Therapy Products, Cell Therapy Products, Tissue-Engineered Products, Stem Cells, cell culture, Viral Vector, Enzymes, Kits and Reagents, Animal models, Molecular diagnostics, Others), By End-user (Academic Research Institutes, CMOs & CROs, Pharmaceutical & Biotechnology Companies, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Red Biotechnology segments across 22 countries from 2021 to 2032. ... Read More
-
Serum-free Media Market Size, Share, and Outlook, 2025 Report- By Product (Classical Media, Specialty Media, Stem Cell Media, Others), By End-user (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, Others), By Application (Bioproduction, Vaccine Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Serum-free Media segments across 22 countries from 2021 to 2032. ... Read More
-
T-Cell Therapy Market by Type of Therapy (CAR-T, TCR and TIL), Target Indication, Target Antigen (BCMA, CD19, CD20, CD19 and CD22, HLA, MAGE, PRAME, NY-ESO-1 and LAGE, EBV, HBV and Others), Company Size (Small, Mid-sized and Large), Geographical Regions (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World), Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts, Till 2035
... 12% during the forecast period, till 2035. The opportunity for the T-cell therapy market has been distributed across the following segments: Type of Therapy CAR-T TCR TIL Target Indication Multiple Myeloma Large B-Cell Lymphoma Acute ... Read More
-
Targeted Drug Delivery Device Market (2nd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Device (Catheters, Cannulas and Others), Target Organ (Brain, Breast, Eyes and Heart), Type of Therapy Delivered (Cell Therapies, Gene Therapies and Immunotherapies), Route of Administration (Intratumoral, Transendocardial and Others), Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Ophthalmic Disorders and Neurological Disorders) and Key Geographical Regions (North America, Europe and Asia-Pacific), and Leading Players and Sales Forecast
... CAGR of 19.7% during the forecast period, till 2035. The opportunity for targeted drug delivery device market has been distributed across the following segments: Type of Device Cannula Catheter Others Type of Organ Brain Breast ... Read More
-
CAR T Cell Therapy Market, By Targeted Antigen (CD19, BCMA, HER2, GD2, CD20, CD22, CD30, CD33, HER1, Others (CLDN18, etc.)), By Therapeutic Application (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Glioblastoma, Sarcoma, Neuroblastoma, Acute Myeloid Leukemia, Breast Cancer, Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... altering in T cells. For chimeric antigen receptor (CAR)-T cell therapy, T cells are extracted from human body using a procedure called leukapheresis. Then after extraction, T cells are altered by adding the gene for ... Read More
-
3D Cell Culture Market, By Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, Microchips), By Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, Stem Cell Biology), By End User (Research Labs & Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. 3D cell cultures can be grown with or without a supporting scaffold. They are usually grown in ... Read More
-
US Apheresis Service Market Research Report Information by Service Type (Donor/Automated Apheresis, Therapeutic Apheresis, and Stem Cell Collection and Processing), by Application (Neurological Disorders, Autoimmune Disorders, Hematologic Disorders, Oncology, Metabolic Toxicology Disorders, Infectious Diseases, Cardiovascular Disorders, and Others), by End User (Hospitals, Blood Banks, Specialty Clinics, Research Laboratories, and Biotechnology Pharmaceutical Companies) Industry Forecast to 2035
... specific component (such as plasma, platelets, or white blood cells), and returning the remaining blood to the body. It is commonly employed for therapeutic objectives, including as removing excess components in particular disorders (for example, ... Read More
-
Global Induced Pluripotent Stem Cells Market, By Cell Source (Skin derived iPSCs, Blood derived iPSCs, Urine Derived iPSCs, Hepatocytes derived iPSCs, Lung fibroblast derived iPSCs and Others), By Application (Culture & Maintenance, Differentiation, Genetic Manipulation & Engineering, Characterization & Validation, Banking & Storage and Others), By End User (Hospitals, Diagnostics Centers, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... provided an ethically superior alternative to embryonic stem cells. Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like pluripotent state. iPSCs are used in regenerative medicine ... Read More
-
Cell Therapy Technologies Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
Research Assistance
